Prothena appoints Dr. William H. Dunn, Jr. to Board of Directors

PROTHENA CORP PUBLIC LTD CO

Dr. William H. Dunn, Jr., M.D. appointed to Board effective May 16, 2023.
Board size increased to accommodate the new appointment.
Dr. Dunn will receive standard non-employee director compensation per 2023 proxy.
He will enter into the Company's standard Deed of Indemnification.
No arrangements or understandings with others led to his selection; no reportable interests.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

William H. Dunn, Jr., M.D.

Director

PRTA · PROTHENA CORP PUBLIC LTD CO

Effective: 2023-05-16
Filed: May 16, 2023, 7:59 PM ET

On May 16, 2023, the Board of Directors (the “Board”) of Prothena Corporation plc (the “Company”) increased the size of the Board and appointed William H. Dunn, Jr., M.D. to serve as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

William H. Dunn, Jr., M.D. was appointed as Director at PROTHENA CORP PUBLIC LTD CO.

Action: appointed
Role: Director

Exact text from the filing

On May 16, 2023, the Board of Directors (the “Board”) of Prothena Corporation plc (the “Company”) increased the size of the Board and appointed William H. Dunn, Jr., M.D. to serve as a director of the Company, effective immediately.

View on SEC.gov

PROTHENA CORP PUBLIC LTD CO filing history →

Source: SEC EDGAR

accession 0001559053-23-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.